Friday, November 11, 2011

NIH HIV Incidence Assays with Improved Specificity (R01)

This grant encourages applications from institutions/ organizations that propose to develop improved HIV Incidence Assays with increased specificity and reliability for distinguishing incident from chronic HIV infections, especially cost-effective assays and algorithms with improved specificity and reliability for determining HIV incidence.  Ideally, the assay would be accurate for diverse HIV-1 subtypes and could be performed in resource limited settings.


For more information, go to: http://grants.nih.gov/grants/guide/pa-files/PA-12-012.html

Application budgets are not limited, but need to reflect actual needs of the proposed project.  The next deadline is 7 January 2011.  The deadline following that one will be 7 May 2011.

Tuesday, November 1, 2011

NIH Exploratory Developmental Research Grant Program (Parent R21)

The R21 mechanism is intended to encourage new exploratory and developmental research projects

All subjects and disciplines are eligible, but the research must be high-risk, high-impact, and highly innovative.

For example, such projects could assess the feasibility of a novel area of investigation or a new experimental system that has the potential to enhance health-related research.  Another example could include the unique and innovative use of an existing methodology to explore a new scientific area. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.

This grant is worth $275,000 over 2 years.  The nearest deadline is 16 February 2012



For more information, see: http://grants.nih.gov/grants/guide/pa-files/PA-10-069.html

NIH Research Project Grant (Parent R01)

The Research Project Grant (R01) is an award made to an institution/organization to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in areas representing the specific interests and competencies of the investigator(s). All disciplines/subjects are eligible to apply.


The R01 research plan proposed by the applicant institution/organization must be related to the stated program interests of one or more of the NIH Institutes and Centers (ICs) based on descriptions of their programs (contact the Faculty of Tropical Medicine Office of Research Services for assistance identifying which IC to apply to).


For more information, see:
http://grants.nih.gov/grants/guide/pa-files/PA-11-260.html


The funding is for 3-5 years and the budget depends on the scope of the project.


The next deadline is 5 February 2011.  There are regular deadlines every February, June, and October.

The Gates Vaccine Innovation Award

The Gates Foundation invites you to nominate individuals or a group of individuals who have achieved significant improvements in the prevention, control, or elimination of vaccine-preventable diseases through immunization.  Nominees will be assessed on three broad criteria:

  • Impact – The nominee should have achieved significant improvements in the prevention, control, or elimination of vaccine-preventable disease.
  • Innovation and creativity – The nominee should have applied imaginative and pioneering approaches to overcome difficult challenges to immunizing children and achieving impact.
  • Scale – The nominee’s innovation should be at scale or suitable to be implemented at scale within the nominee’s country and around the world.

This award is focused ONLY on programs and policies associated with achieving impact through the delivery of vaccines.

The award winner will be recognized with $250,000 (U.S.) and personally acknowledged by Gates Foundation leadership.

Nominations will be accepted through 11:30 AM Pacific Standard Time on November 17, 2011.